Company news

Dermata Therapeutics, Inc. news in 2026

Dermata Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Dermata Highlights Additional Results and Photos from Cosmetic Study Evaluating Its Tome Foundational Treatment

November 17, 2026

Q3 2026 Earnings Release

November 10, 2026

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Third Quarter 2026

November 10, 2026

Dermata Therapeutics Highlights Media Recognition of Tome Skincare Following Commercial Launch

November 5, 2026

Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial

October 29, 2026

Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment

October 15, 2026

Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment

August 25, 2026

Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

August 17, 2026

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026

August 11, 2026

Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment

August 5, 2026

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026

May 13, 2026

Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System

April 1, 2026

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025

March 25, 2026

Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing

March 9, 2026

Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office

January 20, 2026